Discrepancies in international normalized ratio results between instruments: A model to split the variation into subcomponents

Clinical Chemistry

Volumn 56, Issue 10, 2010, Pages 1618-1626

  Sølvik, Una Ø ^a   Petersen, Per H ^a   Monsen, Grete ^b   Stavelin, Anne V ^a,b   Sandberg, Sverre ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b Haraldsplass Hospital   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ACCURACY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BIOCHEMICAL EQUIPMENT; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; MALE; COMPARATIVE STUDY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CALIBRATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; WARFARIN;

EID: 77957731819     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.146233     Document Type: Article

References (38)

1. WHO Expert Committee on Biological Standardization. Requirements for thromboplastins and plasmas used to control oral anticoagulant therapy. World Health Organ Tech Rep Ser 1983;687:81-105.
2. WHO Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. World Health Organ Tech Rep Ser 1999;889:64-93.
3. Horsti J, Uppa H, Vilpo JA. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. Clin Chem 2005;51:553-60. (Pubitemid 40300231)
4. Jackson CM, Esnouf MP, Lindahl TL. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy. Pathophysiol Haemost Thromb 2003;33:43-51.
5. Attermann J. Inaccuracy of international normalized ratio (INR) measurements and suggestions for improved WHO guidelines for calibration of reference preparations; a statistical study. J Thromb Haemost 2003;1:537-44.
6. Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D'Angelo A. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system. Haematologica 2002;87:1265-73. (Pubitemid 36005301)
7. van den Besselaar AMHP. Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis 1996;26(suppl 4):248-65.
8. Quick AJ. The prothrombin in hemophilia and obstructive jaundice. J Biol Chem 1935;109:73-84.
9. Owren PA. Thrombotest: a new method for controlling anticoagulant therapy. Lancet 1959;2:754-8.
10. Tripodi A, Chantarangkul V, Mannucci P. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001;113:847-52. (Pubitemid 32634748)
11. Poller L, Keown M, Chauhan N, van den Besselaar AMHP, Tripodi A, Shiach C, et al. European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Br J Haematol 2003;122:944-9. (Pubitemid 37174615)
12. Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost 1993;70:921-4.
13. Jonsson M, Hillarp A, Svensson P. Comparison between CoaguChek S-and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Thromb Res 2004;114:83-9. (Pubitemid 39078580)
14. Taborski U, Braun SL, Voller H. Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method. J Thromb Thrombolysis 2004;18:103-7. (Pubitemid 40485115)
15. Shermock KM, Bragg L, Connor JT, Fink J, Mazzoli G, Kottke-Marchant K. Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy 2002;22:1397-404. (Pubitemid 35266375)
16. Bereznicki L, Jackson S, Peterson G, Jeffrey E, Marsden K, Jupe D. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2006;60:311-4. (Pubitemid 46447750)
17. Plesch W, van den Besselaar AMHP. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 2009;31:20-5.
18. van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000;84:410-2.
19. Scandinavian evaluation of laboratory equipment for primary health care (SKUP). http://www.skup.nu (Accessed September 2010).
20. Attermann J, Andersen N, Korsgaard H, Maegaard M, Hasenkam J. Patient-specific errors in agreement between international normalized ratios measured by a whole blood coagulometer and by a routine plasma-based method. Haematologica 2004;89:504-5. (Pubitemid 38798562)
21. Tripodi A, Breukink-Engbers W, van den Besselaar AMHP. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of. Semin Vasc Med 2003;3:243-54. (Pubitemid 37280713)
22. van Geest-Daalderop JHH, Mulder AB, Boonman-de Winter LJM, Hoekstra MMCL, van den Besselaar AMHP. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005;51:561-8.
23. Salvagno GL, Lippi G, Montagnana M, Franchini M, Poli G, Guidi GC. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol 2009;31:462-7.
24. NCCLS. Collection, transport and processing of blood specimens for coagulation testing and general performance of coagulation assays; approved guideline. NCCLS document H21-A4. Wayne (PA): NCCLS; 2003.
25. Lindahl TL, Egberg N, Hillarp A, Odegaard OR, Edlund B, Svensson J, et al. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples. Thromb Haemost 2004;91:1223-31. (Pubitemid 38821281)
26. Scandinavian evaluation of laboratory equipment for primary health care (SKUP). Simple Simon® PT: a system for measurement of prothrombin time [P - PT (INR)] manufactured by Zafena AB, Sweden: report from an evaluation in a hospital laboratory organised by SKUP. http://www.skup.nu (Accessed September 2010). SKUP/2007/57*; Simple Simon PT.
27. Zafena. Simple Simon® PT product documentation. http://www.zafena.se/ English/SimpleSimon (Accessed February 2010).
28. Leichsenring I, Plesch W, Unkrig V, Kitchen S, Kitchen D, Maclean R, et al. Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Thromb Haemost 2007;97:856-61. (Pubitemid 46779971)
29. Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH. Thromb Haemost 1995;74:1597-603.
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
31. Aarsand AK, Petersen PH, Sandberg S. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clin Chem 2006;52:650-6.
32. Burdick RK, Graybill FA. Confidence intervals on variance components. New York: Marcel Dekker; 1992. Statistics: textbooks and monographs, vol 127.
33. Burnett RW. Accurate estimation of standard deviations for quantitative methods used in clinical chemistry. Clin Chem 1975;21:1935-8.
34. Gosselin R, Owings JT, White RH, Hutchinson R, Branch J, Mahackian K, et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000;83:698-703. (Pubitemid 30248517)
35. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-85.
36. Della Valle P, Crippa L, Garlando A, Pattarini E, Safa O, Vigano D'Angelo S, et al. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica 1999;84:1065-74. (Pubitemid 30016578)
37. Fairweather RB, Ansell J, van den Besselaar AMHP, Brandt JT, Bussey H, Poller L, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med 1998;122:768-81. (Pubitemid 28411235)
38. Lind SE, Pearce LA, Feinberg WM, Bovill EG. Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities. SPAF Investigators. Stroke prevention in atrial fibrillation. Blood Coagul Fibrinolysis 1999;10:215-27.